Christopher Clark - Dentsply Sirona Pres and CFO
| XRAY Stock | USD 30.44 0.08 0.26% |
CFO
Mr. Christopher Thomas Clark is President and Chief Operating Officer Technologies of the Company. Mr. Clark currently serves as President and Chief Operating Officer, Technologies. Formerly, Mr. Clark held the title of President and Chief Financial Officer of DENTSPLY since April 2013. His primary responsibilities included strategy and business development activities, all finance functions including investor relations, as well as DENTSPLYs corporate functions for clinical affairs, information technology, manufacturing, human resources, and research and development. Since joining DENTSPLY in September 1992, Mr. Clark held positions of progressive responsibility including Director of Marketing, General Manager Vice President, Executive Vice President, and for six years was the Companys Chief Operating Officer. Mr. Clark is a current Board member for the Dental Trade Alliance. Prior to joining DENTSPLY, Mr. Clark was employed with Procter Gamble in a number of management positions, including Brand Manager of Crest Toothpaste since 2016.
| Age | 54 |
| Tenure | 8 years |
| Professional Marks | MBA |
| Address | 13320-B Ballantyne Corporate Place, Charlotte, NC, United States, 28277-3607 |
| Phone | 844 848 0137 |
| Web | https://www.dentsplysirona.com |
Christopher Clark Latest Insider Activity
Tracking and analyzing the buying and selling activities of Christopher Clark against Dentsply Sirona stock is an integral part of due diligence when investing in Dentsply Sirona. Christopher Clark insider activity provides valuable insight into whether Dentsply Sirona is net buyers or sellers over its current business cycle. Note, Dentsply Sirona insiders must abide by specific rules, including filing SEC forms every time they buy or sell Dentsply Sirona'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Christopher Clark over two weeks ago Disposition of 2425 shares by Christopher Clark of Virgin Group at 1.63 subject to Rule 16b-3 | ||
Christopher Clark over a month ago Disposition of 6485 shares by Christopher Clark of Virgin Group at 1.8164 subject to Rule 16b-3 |
Dentsply Sirona Management Efficiency
The company has return on total asset (ROA) of 0.0241 % which means that it generated a profit of $0.0241 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0372) %, meaning that it created substantial loss on money invested by shareholders. Dentsply Sirona's management efficiency ratios could be used to measure how well Dentsply Sirona manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.04 in 2024. Return On Capital Employed is likely to drop to 0.05 in 2024. At this time, Dentsply Sirona's Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to rise to about 271.9 M in 2024, whereas Total Assets are likely to drop slightly above 3.7 B in 2024.Similar Executives
| Found 14 records | CFO Age | ||
| Christopher Lindop | Haemonetics | 56 | |
| Gregory Matz | The Cooper Companies | 56 | |
| MBA BS | Teleflex Incorporated | 62 | |
| Karleen Oberton | Hologic | 53 | |
| Michael Trimarchi | AngioDynamics | 34 | |
| Brett Sandercock | ResMed Inc | 57 | |
| Raul Parra | Merit Medical Systems | 39 | |
| Scott Lamb | ICU Medical | 55 | |
| Bernard Birkett | Merit Medical Systems | 47 | |
| Timothy Stonesifer | Alcon AG | 57 | |
| William Federici | West Pharmaceutical Services | 57 | |
| Robert McMahon | Hologic | 48 | |
| David Murray | Alcon AG | 55 | |
| James CPA | Haemonetics | 53 | |
Management Performance
| Return On Equity | -0.0372 | ||||
| Return On Asset | 0.0241 |
Dentsply Sirona Leadership Team
Elected by the shareholders, the Dentsply Sirona's board of directors comprises two types of representatives: Dentsply Sirona inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Dentsply. The board's role is to monitor Dentsply Sirona's management team and ensure that shareholders' interests are well served. Dentsply Sirona's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dentsply Sirona's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Maureen MacInnis, Chief Human Resource Officer, Senior Vice President | ||
| Dan Workinger, Treasurer | ||
| Thomas Jetter, Lead Director, Independent Director | ||
| Paula Cholmondeley, Independent Director | ||
| Lisa Yankie, VP Officer | ||
| Francis Lunger, Independent Director | ||
| Andrew Robinson, VP Officer | ||
| Kevin Boyle, Senior Officer | ||
| Christopher Clark, Pres and CFO | ||
| Deborah Rasin, Vice President General Counsel, Secretary | ||
| Betsy Holden, Director | ||
| Donald Casey, CEO, Director | ||
| Derek Leckow, VP, Investor Relations | ||
| Andreas Frank, Executive Officer | ||
| Nicholas Alexos, Executive Vice President Chief Administrative Officer | ||
| Daniel Key, Senior Vice President Chief Supply Chain Officer | ||
| Justin McCarthy, General Counsel, Secretary | ||
| Albert Sterkenburg, Senior Vice President | ||
| Markus Boehringer, Senior Vice President - EMEA RCO | ||
| Erania Brackett, SVP Sustainability | ||
| Walter Petersohn, Senior Vice President Chief Commercial Officer | ||
| William Hecht, Lead Independent Director | ||
| Jonathan Friedman, Senior Vice President General Counsel, Secretary | ||
| Mark Thierer, Interim CEO | ||
| Cord Staehler, VP CTO | ||
| Bret Wise, Chairman, CEO and Chairman of Executive Committee | ||
| Glenn Coleman, Executive CFO | ||
| Henning Mueller, Group Vice President - Asia Pacific RCO | ||
| Ulrich Michel, CFO, Executive Vice President | ||
| Rainer Berthan, Executive Vice President Manufacturing and Supply Chain | ||
| Richard Wagner, Chief Officer | ||
| Cheree Johnson, Chief VP | ||
| Dane Baumgardner, AttorneyInFact | ||
| John Sweeney, vice president IR Contact Officer | ||
| Eric Bruno, Senior Vice President - North America Regional Commercial Organization | ||
| Jorge Gomez, CFO, Executive Vice President | ||
| Andrea Daley, Vice Relations | ||
| Robert Size, Sr. VP | ||
| Harry Kraemer, Director | ||
| Andrea Frohning, Senior Officer | ||
| Michael Coleman, Independent Director | ||
| David Beecken, Director | ||
| Leslie Varon, Director | ||
| Eric Brandt, Independent Director | ||
| Robert Johnson, Senior Officer | ||
| William Newell, Senior Vice President Chief Segment Officer | ||
| Willie Deese, Independent Director | ||
| Simon Campion, President CEO | ||
| Keith Ebling, Executive Vice President General Counsel, Secretary | ||
| John Miles, Independent Director | ||
| Richard Rosenzweig, General Development | ||
| Michael Alfano, Independent Director | ||
| James Mosch, COO and Executive VP | ||
| Emily Miner, Senior Officer | ||
| John Miclot, Independent Director | ||
| Arthur Kowaloff, Director | ||
| Jeffrey Slovin, CEO, Director |
Dentsply Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Dentsply Sirona a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0372 | ||||
| Return On Asset | 0.0241 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 8.34 B | ||||
| Shares Outstanding | 207.63 M | ||||
| Shares Owned By Insiders | 0.36 % | ||||
| Shares Owned By Institutions | 99.64 % | ||||
| Number Of Shares Shorted | 10.46 M | ||||
| Price To Earning | 19.16 X |
Dentsply Sirona Investors Sentiment
The influence of Dentsply Sirona's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Dentsply. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Dentsply Sirona's public news can be used to forecast risks associated with an investment in Dentsply. The trend in average sentiment can be used to explain how an investor holding Dentsply can time the market purely based on public headlines and social activities around Dentsply Sirona. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Dentsply Sirona's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Dentsply Sirona's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Dentsply Sirona's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Dentsply Sirona.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Dentsply Sirona in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Dentsply Sirona's short interest history, or implied volatility extrapolated from Dentsply Sirona options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Dentsply Sirona offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dentsply Sirona's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dentsply Sirona Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dentsply Sirona Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Dentsply Sirona. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Dentsply Stock please use our How to Invest in Dentsply Sirona guide.Note that the Dentsply Sirona information on this page should be used as a complementary analysis to other Dentsply Sirona's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for Dentsply Stock analysis
When running Dentsply Sirona's price analysis, check to measure Dentsply Sirona's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dentsply Sirona is operating at the current time. Most of Dentsply Sirona's value examination focuses on studying past and present price action to predict the probability of Dentsply Sirona's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dentsply Sirona's price. Additionally, you may evaluate how the addition of Dentsply Sirona to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Is Dentsply Sirona's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dentsply Sirona. If investors know Dentsply will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dentsply Sirona listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.178 | Dividend Share 0.56 | Earnings Share (0.62) | Revenue Per Share 18.703 | Quarterly Revenue Growth 0.03 |
The market value of Dentsply Sirona is measured differently than its book value, which is the value of Dentsply that is recorded on the company's balance sheet. Investors also form their own opinion of Dentsply Sirona's value that differs from its market value or its book value, called intrinsic value, which is Dentsply Sirona's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dentsply Sirona's market value can be influenced by many factors that don't directly affect Dentsply Sirona's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dentsply Sirona's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dentsply Sirona is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dentsply Sirona's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.